Daniel Latham Email & Phone Number
Global Program Leader - Libmeldy and Lenmeldy @ Orchard Therapeutics
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Daniel Latham Location
- Basel, BS, CH
Daniel Latham Work
- Global Program Leader - Libmeldy and Lenmeldy @ (November 2022 - Present)
- Non Executive Director @ (January 2025 - February 2026)
- Head Connected Health Product Development (Drug Development) @ (October 2020 - November 2022)
- Head Device Development and LCM (CMC Development) @ (June 2016 - October 2020)
- Team Head - Parenteral Packaging and Device Development (CMC Development) @ (September 2014 - June 2016)
- CMC Technical Project Leader (CMC Development) @ (January 2011 - September 2014)
- Project Leader - Medical Device Development (CMC Development) @ (January 2007 - December 2010)
- Project Manager – Scholl Licensed Products (Innovations and Marketing) @ (January 2005 - January 2007)
- Senior Scientific Officer @ (January 2003 - January 2005)
- Scientific Officer @ (January 2000 - January 2003)
- Regulatory Affairs Officer @ (January 1997 - January 1998)
Daniel Latham Education
- Queen Mary University of London
PhD (Controlled drug delivery systems)
2002-2006 - The University of Sheffield
M.Sc (Medical Physics and Clinical Engineering)
1999-2000 - The University of Sheffield
B.Eng (hons) (Biomaterials)
1996-1999
Daniel Latham Skills
- Program Management
- Patient Outcomes
- Targeted Drug Delivery
- Customer Insight
- Innovation Management
- Fast-Moving Consumer Goods (FMCG)
- Manufacturing Scale-up
- Design Control
- Device Development
- Packaging Design
- CMC Regulatory Affairs
- Project Management
- Medical Device R&D
- Combination Products
- Risk Management
- Verification and Validation (V&V)
- Human Factors Engineering
- Physical Testing
- primary packaging
- Agile & Waterfall Methodologies
- Medical Device Regulation (MDR)
- Digital Strategy
- Systems Engineering
- Behavioral Science
- Product Innovation
- Pharmaceutical Industry
- R&D
- Technology Transfer
- Drug Delivery
- Regulatory Affairs
- Medical Devices
- Pharmaceutics
- Analytical Chemistry
- FDA
- Quality System
- GLP
- Product Development
- GMP
- Drug Development
- Formulation
- Manufacturing
- Product Launch
- Regulatory Submissions
- Cross-functional Team Leadership
- Strategy
- Biopharmaceuticals
- Laboratory
- Research and Development (R&D)
- U.S. Food and Drug Administration (FDA)
- Regulatory Requirements
- Management
- Public Speaking
- Research and Development R&d
- Cross Functional Team Leadership
- Healthcare
- Research
- U.S. Food And Drug Administration Fda
- Research and Development
- u.s. Food and Drug Administration
Daniel Latham Summary
- Daniel Latham, based in Basel, BS, CH, is currently a Global Program Leader - Libmeldy and Lenmeldy at Orchard Therapeutics. Daniel Latham brings experience from previous roles at KAHLITY GmbH and Novartis. Daniel Latham holds a 2002 - 2006 PhD in Controlled drug delivery systems @ Queen Mary University of London. With a robust skill set that includes Program Management, Patient Outcomes, Targeted Drug Delivery, Customer Insight, Innovation Management and more. Daniel Latham has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Daniel Latham?
Find contact details for 700 million professionals.
Others Named Daniel Latham
Daniel Latham
Sr. Enterprise Consultant
Midlothian, VA, US
Daniel Latham
Chief Executive Officer
Urbandale, IA, US
Daniel Latham
Senior Vice President - Investment Officer
Cleveland, OH, US
Daniel Latham
President
Hillsboro, MO, US
Daniel Latham
Production Manager
Richmond, VA, US
Daniel Latham
Operations Manager
Leeds, Leeds, United Kingdom
Daniel Latham
Senior Commercial Manager
Crewe, GB
Daniel Latham
Staff Engineer
Birmingham, AL, US
Daniel Latham
M+E Project Engineer
Worksop, GB
Top Orchard Therapeutics Employees
Robin Kenselaar
Chief Commercial Officer
Amsterdam, NH, NL
Chris Northey
Senior Vice President, Corporate Strategy and Portfolio Management
Surrey, Surrey, United Kingdom
Paul Heal
VP of Preclinical Development
Harrogate, GB
Andreas Schuil
Vice President and General Manager EMEA
The Hague, ZH, NL
Bobby Gaspar
Chief Executive Officer
London, GB
Brian Campbell
VP and GM, US
Boston, MA, US
Guido Schopen
VP and General Manager D-A-CH Region
Düsseldorf, NRW, DE
Brian O'Connor
Vice President, Global Quality
Singapore, Central Singapore, Singapore
Nicoletta Loggia
Chief Technical Officer
Basel, BS, CH
James Fettiplace
VP, Clinical Development
Royston, GB
Carl Deluca
Chief Technology Officer
Basel, BS, CH
Laura Campbell
Chief Medical Officer
London, GB
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co